NCT05784103

Brief Summary

Pulse oximeters are common medical devices used to measure blood oxygen saturation (SpO2). These devices are either stand-alone or integrated into physiologic monitoring systems, using 2 wavelengths of light to determine SpO2. With recent advances in technology, Spatial Frequency Domain Imaging (SFDI) uses a range of light wavelengths from red to near-infrared (NIR), and smartphones such as Apple Watch, and transcutaneous oximetry TCOM now have pulse oximetry capabilities. Since it is possible that most patients could utilize this technology, we sought to assess the accuracy, reliability, and usability of these oximeters and compare outcomes. In this study, a cohort of 20 healthy volunteers above the age of 18 including males and females of different skin colors will be assessed at the same site and data will be compared. We aim to provide a set of data that will support the clinical and scientific community and identify more than one reliable skin oxygen measurement modality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 9, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 7, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 7, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

March 13, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 24, 2023

Completed
8 months until next milestone

Results Posted

Study results publicly available

November 24, 2023

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

4 months

First QC Date

March 13, 2023

Results QC Date

April 17, 2023

Last Update Submit

November 27, 2023

Conditions

Keywords

SFDI, oxygenation, healthy volunteers

Outcome Measures

Primary Outcomes (3)

  • Device-wise Comparison of Tissue Oxygenation Measurement

    4 devices used to measures the tissue oxygen saturation on healthy human volunteers

    Visit 1, up to 2 hours in duration

  • Male vs Female Comparison of Tissue Oxygenation Measurement

    Goal is to see if there is a variation in the gender biased. The criteria for the male vs female comparison were considered to find better or worse outcomes.

    1 visit, 2hrs

  • Skin Type Based Comparison of Tissue Oxygenation

    Fitzpatrick chart-based skin categorization of the skin type. The criteria for the Fitzpatrick Skin Type grades IV, II \& III were matched with Fitzpatric table and grades were considered to find better or worse outcomes. Please Note: The skin type analysis was performed irrespective to the devices. Only skin types were considered. So, there is no need of adding arms/groups other than the (1) Skin type IV and (2) the skin type II\& III.

    1 visit, 2hrs duration

Study Arms (1)

Multi-Modal Measurement of Oxygen Saturation

OTHER

During a single study visit, participants will have oxygen saturation measured with a number of oximetry devices including Spatial Frequency Domain Imaging (SFDI), Transcutaneous oxygen monitoring (TCOM), an Apple Watch Oxygen Sensor, and a Pulse Oximeter. Each device will be used to measure oxygen saturation of the thumb and index fingers at rest, during occlusion of blood flow to the arm (using an inflated blood pressure cuff applied to the arm), and during the hyperemic post-occlusion period. Completion of all planned interventions may take up to 2 hours on the study visit day.

Device: Clarifi ModulumDevice: Perimed PeriFlux 5000Device: Apple Watch Oxygen SensorDevice: Innovo iP 900AP

Interventions

During consenting period, the Modulim equipment will be calibrated and setup ready for scanning. Subject's volar aspect of the thumb along with the palm surface will be ready to target the optical camera head. Actual scanning takes less than 60 seconds. The images will be processed offline. During processing 3-5 different regions of interest will be taken to measure the oxygen parameters such as tissue oxygen saturation, oxy-hemoglobin, deoxy-hemoglobin, superficial hemoglobin, and sub-surface hemoglobin.

Also known as: Spatial Frequency Domain Imaging (SFDI)
Multi-Modal Measurement of Oxygen Saturation

Transcutaneous oxygen monitoring (TCOM or TcpO2) is a noninvasive, clinically-approved method to obtain skin oxygen levels. The method is quantitative, and measures oxygen delivery to the skin from underlying tissue. Before positioning the electrode, an adhesive fixation ring will be placed on the dry skin on the volar aspect of the thumb and an electrolyte as a contact liquid will be filled half and the probe is aligned into it by rotating clock-wise to fasten it. Recording will be started and waited for the oxygen level to stabilize and a fixed value will be recorded. The probe will be heated to about 45oC. Although this device has other options, only the measurement of O2 will be performed using this device.

Also known as: Transcutaneous oxygen monitoring (TCOM)
Multi-Modal Measurement of Oxygen Saturation

The apple watch is equipped with green, red, and infrared LEDs that shine light onto the blood vessels in the wrist, with photodiodes measuring the amount of light reflected back. Apple's algorithms use this information to calculate the color of the blood, which is an indication of how much oxygen is in the blood. Bright red blood is well oxygenated, while darker blood has less oxygen. This can measure blood oxygen levels between 70 and 100 percent. Most healthy people have blood oxygen levels that range from 95 to 100 percent. The apple watch sensor will be positioned on the user's preferred wrist.

Multi-Modal Measurement of Oxygen Saturation

The pulse oximeter enables transcutaneous monitoring of the oxygen saturation of hemoglobin in arterial blood. In this study, volar aspect of thumb and index finder of the subject will be used to measure blood oxygen saturation.

Also known as: Pulse Oximeter
Multi-Modal Measurement of Oxygen Saturation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers
  • Able to understand and complete the Informed Consent
  • Both males and females
  • Age between 18-65 years
  • All ethnic backgrounds

You may not qualify if:

  • Patients or limited health conditions
  • Smoking tobacco product
  • Prisoners
  • Cannot consent for themselves

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Indiana University, School of Medicine

Indianapolis, Indiana, 15219/46202, United States

Location

Surya C. Gnyawali, University of Pittsburgh, UPMC

Pittsburgh, Pennsylvania, 15227, United States

Location

Related Publications (2)

  • Jones MD, Taylor JL, Barry BK. Occlusion of blood flow attenuates exercise-induced hypoalgesia in the occluded limb of healthy adults. J Appl Physiol (1985). 2017 May 1;122(5):1284-1291. doi: 10.1152/japplphysiol.01004.2016. Epub 2017 Feb 9.

  • El Masry M, Li R, Balasubramani GK, Roy S, Sen CK, Gnyawali SC. Comparative assessment of healthy tissue oxygenation using near-infrared imaging, transcutaneous oxygen measurement, and plethysmography. Sci Rep. 2025 Aug 19;15(1):30424. doi: 10.1038/s41598-025-15767-2.

Limitations and Caveats

The study includes a small cohort of 20 volunteers. Aim was to include dark skin volunteers but that was not successful.

Results Point of Contact

Title
Dr. Surya Gnyawali, PhD
Organization
University of Pittsburgh

Study Officials

  • Surya C. Gnyawali, PhD

    University of Pittsburgh and Indiana University, School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Professor

Study Record Dates

First Submitted

March 13, 2023

First Posted

March 24, 2023

Study Start

March 9, 2022

Primary Completion

July 7, 2022

Study Completion

July 7, 2022

Last Updated

November 29, 2023

Results First Posted

November 24, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Through Publication

Locations